search
Back to results

A Mobile Application Based Dietary Self Management Intervention in Chinese Chronic Kidney Disease Patients (CRISS-MADE)

Primary Purpose

Chronic Renal Disease

Status
Unknown status
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
Mobile Application for Dietary Management
Sponsored by
Peking Union Medical College Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Chronic Renal Disease focused on measuring Chronic Renal Disease, Dietary Management, Mobile Application

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Diagnosed with CKD for more than 3 months
  • Objective measures of kidney disease (fulfill one of the following): 1) eGFR≤60ml/min/1.73m^2; 2) Proteinuria (Protein + on dipstick or 24 hour urine protein>0.3g or albumin-to-creatinine ratio (ACR) >30mg/mmol or protein-to-creatinine ratio (PCR) >50mg/mmol); 3) Imaging proven kidney disease (Atrophy, stone formation, cystic kidney disease, or other structural abnormality)
  • Having access to a mobile phone and is capable of using the dietary intervention application

Exclusion Criteria:

  • Can not provide history of kidney disease or can not provide laboratory result for the past 3 month
  • Can not use a mobile phone or deemed unfit to participate by their treating nephrologist

Sites / Locations

  • Peking Union Medical College Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Mobile Application Intervention

Care as Usual

Arm Description

Participants in this arm will receive mobile application dietary intervention as well as usual CKD dietary care.

Participants in this arm will receive usual CKD dietary care.

Outcomes

Primary Outcome Measures

Dietary Intake
Dietary intake of calorie, protein, sodium, potassium and phosphate evaluated by three-day diet records (3DDR)
Diet Quality
Calculated by Chinese Healthy Eating Index
Blood Pressure
Measure BP in office visits after the intervention period. Changes in antihypertensive medication requirements (total number, dose, class) will be collected from participants and verified with hospital records.
change in estimated Glomerular Filtration Rate (eGFR)
blood draw (fasting) before and after intervention period
Change in Proteinuria
spot urine before and after intervention period
Change in Disease Related Quality of life
Measured by Kidney Disease Quality of Life 36-Short Form questionnaire
Change in Self-Efficacy for Managing Chronic Disease Scale
Score of Self-Efficacy for Managing Chronic Disease Scale (6 items, each measured on a 1-10 likert scale, higher score indicate better self-efficacy) before and after intervention period
Change in Perceived Medical Condition Self-Management Scale (PMCSMS)
Measured by Perceived Medical Condition Self-Management Scale (8-item CKD-specific version of the PMCSMS, each item is scored on a 1-5 likert scale, with higher score indicating better self management on item 3/4/5/8 and lower score indicating better self management on item 1/2/6/7) before and after intervention

Secondary Outcome Measures

Blood Chemistry (Potassium, Bicarbonate, Phosphate)
blood draw (fasting) before and after intervention period
Urine Sodium/potassium Ratio
Measured by spot urine at baseline and after intervention
Salt Taste Threshold
Salt taste threshold measured using salt-impregnated test strips before and after the intervention period
Kidney Nutrition Knowledge, Attitude and Practice
Measured by self developed questionnaire about knowledge, attitude and practice in kidney disease specified diet
Acceptability of the Application
Measured by user acceptability survey and semistructured interviews conducted in participants and nephrologists
Adherence
Total number of diet diary logged by participants over complete study period (more than 60% logged is deemed good adherence)
Adoption
Measured by percentage of complete dietary log in days will be counted (>1200kcal deemed as complete log)
Change in the score of Generalized Anxiety Disorder Scale
Measured by Generalized Anxiety Disorder Scale (a 7-item self-report scale. Items are rated on a 4-point Likert-scale with 0 = not at all to 3 = nearly every day ) before and after intervention
Change in the score of Hospital Anxiety and Depression Scale
Measured by Hospital Anxiety and Depression Scale (14 items each rated on a 0-3 score, with higher score indicating worse anxiety or depression symptoms) before and after intervention

Full Information

First Posted
May 31, 2021
Last Updated
June 23, 2021
Sponsor
Peking Union Medical College Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT04940819
Brief Title
A Mobile Application Based Dietary Self Management Intervention in Chinese Chronic Kidney Disease Patients
Acronym
CRISS-MADE
Official Title
A Mobile Application Based Dietary Self Management Intervention in Chinese Chronic Kidney Disease Patients: a Multi-Center Randomized Controlled Study
Study Type
Interventional

2. Study Status

Record Verification Date
June 2021
Overall Recruitment Status
Unknown status
Study Start Date
June 2021 (Anticipated)
Primary Completion Date
June 2023 (Anticipated)
Study Completion Date
June 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Peking Union Medical College Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This is a multi-center randomized controlled study. This study aims to investigate the acceptability and efficacy of a newly developed mobile application in the dietary management of chronic kidney disease (CKD) patients.
Detailed Description
The prevalence of CKD has reached 10.8% in China. Increasing in prevalence of other non-communicable disease such as hypertension, diabetes and obesity is contributing to this rise in CKD and end-stage renal disease prevalence. Diet is a strong modifiable factor in these diseases. Dietary control is also an integral part in CKD disease self management. However, the complexity in the dietary management of CKD makes it hard for patients to adequately self manage. With the development of smart phone, many mobile applications have been developed to suit the need of patients with chronic diseases. But there has been a scarce of randomized trial to support the feasibility, acceptability and efficacy of these mobile applications. Our study aims to employ a newly developed dietary logging and monitoring application in the primary care setting of CKD patients to test its acceptability and efficacy in disease control. The application is developed by a multidisciplinary team in a tertiary care center. The main features include searching and logging foods, receiving realtime feedback on key nutrient intake levels and facilitating patient-care giving communication. We plan to enroll 14 tertiary hospitals and 42 secondary hospitals in 7 geographical regions in China aiming to reach participants in resource poor areas. Participants will be randomized with 1 to 1 ratio to either receiving mobile application dietary intervention or usual dietary consultation. The planned intervention period is 3 months. We will monitor biochemical parameters relating to dietary control and evaluate patient-centered outcomes concerning CKD self management and control.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chronic Renal Disease
Keywords
Chronic Renal Disease, Dietary Management, Mobile Application

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
9863 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Mobile Application Intervention
Arm Type
Experimental
Arm Description
Participants in this arm will receive mobile application dietary intervention as well as usual CKD dietary care.
Arm Title
Care as Usual
Arm Type
No Intervention
Arm Description
Participants in this arm will receive usual CKD dietary care.
Intervention Type
Behavioral
Intervention Name(s)
Mobile Application for Dietary Management
Intervention Description
A mobile application developed by a multi-disciplinary team will be used in the dietary management of CKD patients. The application is patient orientated. It has 4 core features including food searching, dietary logging, personalized key nutrient intake feedback and patient-caregiver interaction.
Primary Outcome Measure Information:
Title
Dietary Intake
Description
Dietary intake of calorie, protein, sodium, potassium and phosphate evaluated by three-day diet records (3DDR)
Time Frame
3 months
Title
Diet Quality
Description
Calculated by Chinese Healthy Eating Index
Time Frame
3 months
Title
Blood Pressure
Description
Measure BP in office visits after the intervention period. Changes in antihypertensive medication requirements (total number, dose, class) will be collected from participants and verified with hospital records.
Time Frame
3 months
Title
change in estimated Glomerular Filtration Rate (eGFR)
Description
blood draw (fasting) before and after intervention period
Time Frame
3 months
Title
Change in Proteinuria
Description
spot urine before and after intervention period
Time Frame
3 months
Title
Change in Disease Related Quality of life
Description
Measured by Kidney Disease Quality of Life 36-Short Form questionnaire
Time Frame
3 months
Title
Change in Self-Efficacy for Managing Chronic Disease Scale
Description
Score of Self-Efficacy for Managing Chronic Disease Scale (6 items, each measured on a 1-10 likert scale, higher score indicate better self-efficacy) before and after intervention period
Time Frame
3 months
Title
Change in Perceived Medical Condition Self-Management Scale (PMCSMS)
Description
Measured by Perceived Medical Condition Self-Management Scale (8-item CKD-specific version of the PMCSMS, each item is scored on a 1-5 likert scale, with higher score indicating better self management on item 3/4/5/8 and lower score indicating better self management on item 1/2/6/7) before and after intervention
Time Frame
3 months
Secondary Outcome Measure Information:
Title
Blood Chemistry (Potassium, Bicarbonate, Phosphate)
Description
blood draw (fasting) before and after intervention period
Time Frame
3 months
Title
Urine Sodium/potassium Ratio
Description
Measured by spot urine at baseline and after intervention
Time Frame
3 months
Title
Salt Taste Threshold
Description
Salt taste threshold measured using salt-impregnated test strips before and after the intervention period
Time Frame
3 months
Title
Kidney Nutrition Knowledge, Attitude and Practice
Description
Measured by self developed questionnaire about knowledge, attitude and practice in kidney disease specified diet
Time Frame
3 months
Title
Acceptability of the Application
Description
Measured by user acceptability survey and semistructured interviews conducted in participants and nephrologists
Time Frame
3 months
Title
Adherence
Description
Total number of diet diary logged by participants over complete study period (more than 60% logged is deemed good adherence)
Time Frame
3 months
Title
Adoption
Description
Measured by percentage of complete dietary log in days will be counted (>1200kcal deemed as complete log)
Time Frame
3 months
Title
Change in the score of Generalized Anxiety Disorder Scale
Description
Measured by Generalized Anxiety Disorder Scale (a 7-item self-report scale. Items are rated on a 4-point Likert-scale with 0 = not at all to 3 = nearly every day ) before and after intervention
Time Frame
3 months
Title
Change in the score of Hospital Anxiety and Depression Scale
Description
Measured by Hospital Anxiety and Depression Scale (14 items each rated on a 0-3 score, with higher score indicating worse anxiety or depression symptoms) before and after intervention
Time Frame
3 months
Other Pre-specified Outcome Measures:
Title
Change in Chronic Kidney Disease Self-Efficacy Instrument
Description
Score of Chronic Kidney Disease Self-Efficacy Instrument before and after intervention period
Time Frame
3 months
Title
Change in Kidney Disease Behaviors Inventory
Description
Kidney Disease Behaviors Inventory before and after intervention
Time Frame
3 months

10. Eligibility

Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Diagnosed with CKD for more than 3 months Objective measures of kidney disease (fulfill one of the following): 1) eGFR≤60ml/min/1.73m^2; 2) Proteinuria (Protein + on dipstick or 24 hour urine protein>0.3g or albumin-to-creatinine ratio (ACR) >30mg/mmol or protein-to-creatinine ratio (PCR) >50mg/mmol); 3) Imaging proven kidney disease (Atrophy, stone formation, cystic kidney disease, or other structural abnormality) Having access to a mobile phone and is capable of using the dietary intervention application Exclusion Criteria: Can not provide history of kidney disease or can not provide laboratory result for the past 3 month Can not use a mobile phone or deemed unfit to participate by their treating nephrologist
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Xixi Zheng, MD
Phone
+8613521145030
Email
zxxpumch@163.com
First Name & Middle Initial & Last Name or Official Title & Degree
Peng Xia, MD
Phone
+8613811684903
Email
7-xp@163.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Limeng Chen, MD, PhD
Organizational Affiliation
Peking Union Medical College Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Peking Union Medical College Hospital
City
Beijing
State/Province
Beijing
ZIP/Postal Code
100730
Country
China
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Xixi Zheng, MD
Phone
+8613521145030
Email
zxxpumch@163.com
First Name & Middle Initial & Last Name & Degree
Peng Xia, MD
Phone
+8613811684903
Email
7-xp@163.com
First Name & Middle Initial & Last Name & Degree
Limeng Chen, MD, PhD

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
22386035
Citation
Zhang L, Wang F, Wang L, Wang W, Liu B, Liu J, Chen M, He Q, Liao Y, Yu X, Chen N, Zhang JE, Hu Z, Liu F, Hong D, Ma L, Liu H, Zhou X, Chen J, Pan L, Chen W, Wang W, Li X, Wang H. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet. 2012 Mar 3;379(9818):815-22. doi: 10.1016/S0140-6736(12)60033-6. Erratum In: Lancet. 2012 Aug 18;380(9842):650.
Results Reference
background
PubMed Identifier
31425608
Citation
Stevenson JK, Campbell ZC, Webster AC, Chow CK, Tong A, Craig JC, Campbell KL, Lee VW. eHealth interventions for people with chronic kidney disease. Cochrane Database Syst Rev. 2019 Aug 6;8(8):CD012379. doi: 10.1002/14651858.CD012379.pub2.
Results Reference
background
PubMed Identifier
32478665
Citation
Lim JH, Lim CK, Ibrahim I, Syahrul J, Mohamed Zabil MH, Zakaria NF, Daud ZAM. Limitations of Existing Dialysis Diet Apps in Promoting User Engagement and Patient Self-Management: Quantitative Content Analysis Study. JMIR Mhealth Uhealth. 2020 Jun 1;8(6):e13808. doi: 10.2196/13808.
Results Reference
background

Learn more about this trial

A Mobile Application Based Dietary Self Management Intervention in Chinese Chronic Kidney Disease Patients

We'll reach out to this number within 24 hrs